AI assistant
Sending…
Photocure ASA — Director's Dealing 2017
Apr 10, 2017
3714_dirs_2017-04-10_d5cf6e85-cb2f-4708-8076-d48edf42fbcd.html
Director's Dealing
Open in viewerOpens in your device viewer
Photocure ASA (OSE: PHO): Mandatory notification of trade, primary insider
Photocure ASA (OSE: PHO): Mandatory notification of trade, primary insider
On 7 April 2017 Ambaw Bellete - Head, US Cancer Commercial
Operations - purchased 2,000 Photocure shares at a price of
NOK 30.13 each.
Ambaw Bellete now holds 2,000 shares and 76,600 options in
Photocure.
This notification is made pursuant to the Norwegian
Securities Trading Act sections 4-2.
More from Photocure ASA
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 7
Interim / Quarterly Report
2026
May 7
Interim / Quarterly Report
2026
May 7
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 4
Regulatory Filings
2026
May 4
Report Publication Announcement
2026
Apr 30
Report Publication Announcement
2026
Apr 30